USA v. Tanner et al

  1. May 16, 2018

    Feds Show Valeant Jury Spending Records, Doctored Emails

    Prosecutors who charged a manager at drug giant Valeant Pharmaceuticals International Inc. and the CEO of a mail-order pharmacy with defrauding Valeant out of $9.7 million wrapped up their case on Wednesday by showing jurors evidence of email tampering and records of the defendants' outlays on a private jet and a luxury hotel.

  2. May 15, 2018

    Defense Buffeted By Tough Rulings In Valeant Kickback Trial

    Two men who are charged with defrauding Valeant Pharmaceuticals International Inc. out of $9.7 million when it bought an option to acquire Philidor Rx Services LLC were dealt a bad hand by a Manhattan federal judge on Tuesday, with the court rejecting their efforts to have one of Valeant’s lawyers testify and to prevent an FBI agent from undercutting their arguments.

  3. May 14, 2018

    Alleged Valeant Betrayer's Boss Testifies He Was 'Concerned'

    A key witness in the U.S. government's case against Valeant Pharmaceuticals International Inc. manager Gary Tanner, who is accused of scheming to have his employer acquire mail-order pharmacy Philidor Rx Services LLC in exchange for a $9.7 million kickback, told a New York federal jury Monday that he was "concerned" by how close Tanner was with Philidor and what he was doing there.

  4. May 09, 2018

    Ex-Valeant Worker's Emails Show Double-Dealing, Jury Hears

    A former mergers and acquisitions official at Valeant Pharmaceuticals International Inc. took the stand Wednesday to walk jurors through dozens of emails that appeared to show his colleague Gary Tanner helping Philidor Rx Services negotiate against his own employer in a $100 million deal.

  5. May 04, 2018

    Pharma Execs Cast Doubt On Valeant's Compliance Culture

    Two men charged with defrauding Valeant Pharmaceuticals International Inc. out of $9.7 million when it moved to buy Philidor Rx Services LLC sought on Friday to rebut claims they hid anything from Valeant at trial, pressing Valeant's chief compliance officer about her duties and the links between the two companies.

  6. February 23, 2017

    Ex-Valeant, Philidor Execs Deny $40M Kickback Scheme

    Ex-Valeant Pharmaceuticals International Inc. executive Gary Tanner and former Philidor Rx Services LLC CEO Andrew Davenport on Thursday in Manhattan federal court denied charges that they participated in a $40 million merger fraud and kickback scheme.

  7. November 17, 2016

    Bharara Unveils Charges Against Ex-Valeant, Philidor Execs

    Ex-Valeant Pharmaceuticals International Inc. executive Gary Tanner and former Philidor Rx Services LLC CEO Andrew Davenport were arrested Thursday over an alleged $40 million merger fraud and kickback scheme, with Manhattan U.S. Attorney Preet Bharara strongly hinting that more charges were likely in the offing.